Effects of androgen receptor signaling inhibitors on absorbed doses in mCRPC patients undergoing [177Lu]Lu-PSMA-617 or [177Lu]Lu-PSMA-I&T therapy: dosimetry results

Josef Zahner, Astrid Delker, Zachary Ells, Ana Antic Nikolic, Adrien Holzgreve, Sophie C Siegmund, Maximilian Tiling, Mathias J Zacherl, Elena Berg, Can D Aydogdu, Alexander Dierks, Marcus Unterrainer, Guido Böning, Christian Stief, Jeremie Calais, Constantin Lapa, Rudolf A Werner, Jozefina Casuscelli, Lena M Unterrainer · 2026

Read Effects of androgen receptor signaling inhibitors on absorbed doses in mCRPC patients undergoing [177Lu]Lu-PSMA-617 or [177Lu]Lu-PSMA-I&T therapy: dosimetry results by Josef Zahner, Astrid Delker, Zachary Ells, Ana Antic Nikolic, Adrien Holzgreve, Sophie C Siegmund, Maximilian Tiling, Mathias J Zacherl, Elena Berg, Can D Aydogdu, Alexander Dierks, Marcus Unterrainer, Guido Böning, Christian Stief, Jeremie Calais, Constantin Lapa, Rudolf A Werner, Jozefina Casuscelli, Lena M Unterrainer (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13526123.txt.

Description

Josef Zahner leads a large team in a 2026 dosimetry analysis asking whether hormone blocking drugs change radiation doses from PSMA-targeted therapy in advanced prostate cancer. Androgen receptor signaling inhibitors improve results and might raise PSMA expression and tumor dose. Patients got one of two lutetium-177 PSMA radioligands.

The retrospective analysis at one center covered fifty men at their first treatment cycle, half also taking abiraterone or enzalutamide and half on radioligand therapy alone. Imaging at three time points after dosing fed dose math for 148 tumor lesions and for kidney, spleen, and liver. Median tumor dose was comparable between combination and control groups for both radioligands, with no significant differences. Organ doses were also comparable in the results noted, which the authors call preliminary.

Catalog record

CREATORJosef Zahner, Astrid Delker, Zachary Ells, Ana Antic Nikolic, Adrien Holzgreve, Sophie C Siegmund, Maximilian Tiling, Mathias J Zacherl, Elena Berg, Can D Aydogdu, Alexander Dierks, Marcus Unterrainer, Guido Böning, Christian Stief, Jeremie Calais, Constantin Lapa, Rudolf A Werner, Jozefina Casuscelli, Lena M Unterrainer
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31870
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13526123

Browse the full library · About the Tower of Babel